IDEAYA Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery…
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery…
SOUTH SAN FRANCISCO, Calif., Aug. 10, 2021 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a synthetic lethality focused…
This stock looks like a great one to buy sooner rather than later.
The Oracle of Omaha has a knack for picking out time-tested businesses that consistently outperform.
Chevron is a stellar dividend growth opportunity with ample capital appreciation upside as well. Here’s why we view CVX’s capital…
The automotive component manufacturing company’s revenue almost doubled to Rs 16,712 crore from Rs 8,431 crore in June quarter…
The DAX 30 struggles to build demand as sentiment sours on rising Delta variant in the US and China
The stock price of Cigna, a health insurance and pharmacy services management company, reached its all-time high of $267 in May…
EliteCyber is working alongside a well known organization that is looking to hire a VP – Cyber Security to lead and manage their…
Lufax Holding Ltd (NYSE:LU) Q2 2021 Earnings Conference Call August 9, 2021 9:00 PM ETCompany ParticipantsChen Yu – Head of Investor…